New method to cure African sleepiness

The British Journal of Nature published on April 1 said that Canadian and British scientists have found a new way to treat African sleeping sickness (often referred to as African drowsiness).

This finding has important implications for the scientific community to study the preparation of new drugs safe and effective.

Illustration.

African sleepiness is a disease caused by trypanosoma parasites, and is transmitted through the bite of a tsetse fly in Africa.

The disease threatens millions of people in 36 African countries, with an estimated 50,000 to 70,000 people each year.

Scientist Paul Wyatt of the University of Dundee, UK, said he and his colleagues discovered a compound that could damage the enzyme N-acyltransferase (NMT).

N-acyltransferase enzyme has important implications for the life and growth of trypanosoma parasites.

Research has shown that N-acyltransferase inhibitors can quickly kill African drowsiness.

By experimental methods on mice, scientists have successfully treated this disease. However, it takes about 18 months for new scientists to study the preparation of a clinical application of oral medications.

Scientist Paul Wyatt added that some pharmaceutical companies such as GlaxoSmithKline, Merck and Pfizer have announced that they will invest in the field of research into the development of African sleepy medicine.

This move brings hope to improve the current disease situation./.